(Q54977898)

14 June 2018

http://europepmc.org/abstract/MED/29808009

title

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. (English)

1 reference

14 June 2018

http://europepmc.org/abstract/MED/29808009

author

Dietrich A. Ruess

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Derya Kabacaoğlu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Kıvanç Görgülü

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Kalliope N Diakopoulos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

Eveline A Zeeuw van der Laan

31 May 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Marc Nazaré

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

26

Hana Algül

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Guus J Heynen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Katrin J Ciecielski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jiaoyu Ai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Alexandra Berninger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Zahra Dantes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sonja M Wörmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Angeliki F Karpathaki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Marlena Kowalska

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ezgi Kaya-Aksoy

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Liang Song

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

María P López-Alberca

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Maximilian Reichert

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Dieter Saur

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mert M Erkan

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ulrich T Hopt

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Bruno Sainz

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Walter Birchmeier

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Roland M Schmid

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Marina Lesina

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

28 May 2018

1 reference

14 June 2018

http://europepmc.org/abstract/MED/29808009

published in

Nature Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

954-960

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Protein tyrosine phosphatases in the JAK/STAT pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

The tyrosine phosphatase Shp2 (PTPN11) in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

The tyrosine phosphatase Shp2 in development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Drugging the undruggable RAS: Mission possible?

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Activation of a Phosphotyrosine Phosphatase by Tyrosine Phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Chemical Dissection of the Effects of Tyrosine Phosphorylation of SHP-2

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Roles for KRAS in pancreatic tumor development and progression

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

PI3 kinase signals BCR-dependent mature B cell survival

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

A combinatorial strategy for treating KRAS-mutant lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Shp2 signaling suppresses senescence in PyMT-induced mammary gland cancer in mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Drug combination studies and their synergy quantification using the Chou-Talalay method

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

Organoid models of human and mouse ductal pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0024-8

7 January 2021

10.1038/S41591-018-0024-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29808009%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference